Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01266967
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of GSK2118436 in BRAF Mutant Metastatic Melanoma to the Brain
Condition: Melanoma and Brain Metastases
Intervention: Drug: GSK2118436

Study has passed its completion date and status has not been verified in more than two years.